Kathy Astrahantseff

Berlin, BE, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 47 publications

A pilot study combining primary busulfan-based haploidentical stem cell transplantation with GD2 antibody to treat high-risk neuroblastoma.

A pilot study combining primary busulfan-based haploidentical stem cell transplantation with GD2 antibody to treat high-risk neuroblastoma.

Journal: Bone marrow transplantation

Published: January 18, 2026

Current treatment strategies for first relapse of high-risk neuroblastoma.

Current treatment strategies for first relapse of high-risk neuroblastoma.

Journal: European journal of cancer (Oxford, England : 1990)

Published: December 16, 2025

Fractal Dimension of High-Risk Neuroblastoma Vascularity in MRI Is Associated with Chemotherapy Response and Event-Free Survival.

Fractal Dimension of High-Risk Neuroblastoma Vascularity in MRI Is Associated with Chemotherapy Response and Event-Free Survival.

Journal: Radiology. Imaging cancer

Published: December 12, 2025

YAP1 Enhances Mesenchymal-Type Gene Expression in Human Adrenergic-Type Neuroblastoma Cells.

YAP1 Enhances Mesenchymal-Type Gene Expression in Human Adrenergic-Type Neuroblastoma Cells.

Journal: Cancers

Published: December 10, 2025

Multiplexed biomarkers dynamically detect heterogeneous residual neuroblastoma cell clone activity in the bone marrow niche.

Multiplexed biomarkers dynamically detect heterogeneous residual neuroblastoma cell clone activity in the bone marrow niche.

Journal: Cancer letters

Published: October 08, 2025

Investigating genetic modifications to enhance L1CAM-CAR T cell migration in solid tumors in a 3D bioprinted neuroblastoma model.

Investigating genetic modifications to enhance L1CAM-CAR T cell migration in solid tumors in a 3D bioprinted neuroblastoma model.

Journal: Frontiers in immunology

Published: July 31, 2025

Correction: GPOH Guidelines for Diagnosis and First-line Treatment of Patients with Neuroblastic Tumors, update 2025.

Correction: GPOH Guidelines for Diagnosis and First-line Treatment of Patients with Neuroblastic Tumors, update 2025.

Journal: Klinische Padiatrie

Published: June 05, 2025

GPOH Guidelines for Diagnosis and First-line Treatment of Patients with Neuroblastic Tumors, update 2025.

GPOH Guidelines for Diagnosis and First-line Treatment of Patients with Neuroblastic Tumors, update 2025.

Journal: Klinische Padiatrie

Published: May 09, 2025

Cancer evolution and multi-omic profile of relapsed colorectal liver metastases after treatment.

Cancer evolution and multi-omic profile of relapsed colorectal liver metastases after treatment.

Journal: Genome medicine

Published: April 16, 2025

Serially Quantifying TERT Rearrangement Breakpoints in ctDNA Enables Minimal Residual Disease Monitoring in Patients with Neuroblastoma.

Serially Quantifying TERT Rearrangement Breakpoints in ctDNA Enables Minimal Residual Disease Monitoring in Patients with Neuroblastoma.

Journal: Cancer research communications

Published: November 23, 2024

Targeting MYCN upregulates L1CAM tumor antigen in MYCN-dysregulated neuroblastoma to increase CAR T cell efficacy.

Targeting MYCN upregulates L1CAM tumor antigen in MYCN-dysregulated neuroblastoma to increase CAR T cell efficacy.

Journal: Pharmacological research

Published: October 20, 2024

Management of Busulfan-Induced Lung Injury in Pediatric Patients with High-Risk Neuroblastoma.

Management of Busulfan-Induced Lung Injury in Pediatric Patients with High-Risk Neuroblastoma.

Journal: Journal of clinical medicine

Published: September 11, 2024

Showing 1-12 of 47

Last Updated: 09/26/2026